[D2-4-1]Immunogenicity Profile of the Port Delivery System with Ranibizumab in Patients with nAMD
*Mauricio Maia 1, John Lowe 1, Steven Blotner 2, Galin Spicer 3, Natasha Singh 4, Shweta Vadhavkar 5, Derrick Kaufman 6, Ihsan Nijem 1, Weili Yan 1, Han Ting Ding 5, Matts Kaagedal 5, Giulio Barteselli 7, Keshwin Sharma 1, Katie Maass 5(1. Bioanalytical Sciences Department, Genentech/Roche , 2. Data & Statistical Sciences OMNI, Genentech/Roche , 3. Ophthalmology/US Medical Affairs, Genentech/Roche , 4. Clinical Safety Department, Genentech/Roche , 5. Clinical Pharmacology Department, Genentech/Roche , 6. Data & Statistical Science, Genentech/Roche , 7. Ophthalmology, Genentech/Roche )
Password required to view
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.
Password is required to view the abstract. Please enter a password to authenticate.
